TransMedics Group, Inc. SEC filings TMDX

TransMedics Group, Inc. has 630 filings in SEC EDGAR's recent list, going back to Oct 19, 2018. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

TransMedics Group, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 4, 2023 —
424B5 Prospectus supplement Aug 5, 2022 —
424B5 Prospectus supplement Aug 3, 2022 —
S-3ASR Automatic shelf registration Aug 3, 2022 —
S-8 Employee stock plan registration Mar 1, 2022 —
424B5 Prospectus supplement May 27, 2020 —
424B5 Prospectus supplement May 26, 2020 —
S-3 Shelf registration May 6, 2020 —
S-8 Employee stock plan registration May 6, 2019 —
424B4 Prospectus May 2, 2019 —
S-1MEF Filing May 1, 2019 —
S-1/A Amended registration statement May 1, 2019 —
S-1/A Amended registration statement Apr 30, 2019 —
S-1/A Amended registration statement Apr 22, 2019 —
S-1 Registration statement Apr 5, 2019 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
TMDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MA
Headquarters
Andover, MA
SEC filer status
Large accelerated filer
SEC CIK
1756262

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.